Trial intelligence / Profile preview

Estrogen Variability and Irritability During the Menopause Transition

NCT05388656Phase 4Completed

Sponsor
University of North Carolina at Chapel Hill
Start
Jun 2022
Primary completion
Dec 2024
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of estradiol topical in irritability (2 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Mean IDAS Ill Temper Scale Score Over Time at 3 weeks. Started Jun 2022; status: completed.

02

Drugs

estradiol topical
03

Conditions

irritability

Beyond the preview

Go deeper on NCT05388656.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05388656.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call